Nootropics: Effects, Safety, Trends, and EU Legislation

Do nootropics work? Effects, safety, legislation, and market trends in the EU

What are nootropics and how are they classified?

Nootropics (also known as “smart drugs” or “cognitive enhancers”) represent a broad group of substances.

This includes common dietary components (e.g., caffeine), plant extracts, and prescription medications (e.g., modafinil or methylphenidate). Their purpose is to support cognitive functions, particularly alertness, attention, memory, motivation, or performance under mental stress.

Currently, there is no uniform and legally binding definition of nootropics.

Furthermore, many products sold under this label have limited clinical evidence. Effects typically vary depending on the specific situation, such as sleep quality, stress levels, or the individual needs of the user.

In scientific and clinical literature, the terms “nootropics,” “cognitive enhancers,” and “smart drugs” are generally used interchangeably but do not mean the same thing.

These substances are not only used by people with health issues; healthy individuals (such as students or workers) also typically turn to them in an effort to boost performance.

It should be noted that their effects on a healthy brain are often limited and may also carry certain risks.

Classification by regulation and type of effect

For practical purposes, it is useful to classify nootropics by regulation and type of effect:

  • Herbal medicinal products: Some herbal substances (e.g., Ginkgo biloba or Rhodiola rosea) are also available as registered medicines. They are governed by the “herbal medicinal products” regime, and their evaluation is based, among other things, on EMA monographs, which member states take into account.
  • Prescription Medicines: These include, for example, modafinil or methylphenidate. They are intended for specific diagnoses (e.g., narcolepsy or ADHD), and their use outside of approved indications may carry both health and legal risks.

How nootropics work

The mechanism of action varies depending on the specific substance, but generally, they affect brain function.

Most commonly, nootropics affect signal transmission between nerve cells, brain energy metabolism, or the stress response.

They can interfere with various neurotransmitter systems (e.g., cholinergic, glutamatergic, or GABAergic), affect blood flow to the brain, inflammatory and oxidative processes, or cellular energy.

Key neurochemical mechanisms

Cognitive functions are not a “single entity,” as memory, attention, and decision-making have distinct biological foundations. In practice, therefore, nootropics target various mechanisms:

  • Adenosine and alertness (caffeine): Caffeine blocks adenosine receptors, thereby promoting alertness and reducing feelings of fatigue. The EFSA states that, in moderate amounts, it stimulates the central nervous system and helps improve attention.
  • Dopamine and norepinephrine (psychostimulants): Substances such as modafinil or methylphenidate affect the dopaminergic and noradrenergic systems, which is associated with improved attention and alertness. In the case of modafinil, an effect on the dopamine transporter and dopamine reuptake has been described.
  • Cholinergic system (memory and learning): Some substances are associated with increased acetylcholine levels or support for nerve cells. This mechanism is primarily used in the treatment of dementia; in healthy individuals, the effect is typically less pronounced and depends on the individual’s condition.
  • Brain Energy (Creatine): Creatine supports the production of ATP, the basic energy source for cells. This may also play a role in the brain, particularly during high stress or sleep deprivation. Studies in healthy individuals suggest potential cognitive benefits, though results vary.
  • Stress response (adaptogens): Adaptogens, such as rhodiola or ashwagandha, influence the body’s response to stress (e.g., via the hormone cortisol). As a result, they can indirectly support mental performance, primarily by reducing fatigue and improving stress resilience. The EMA describes the adaptogenic concept as “non-specific” support for resilience to stressors.

Nootropics and adaptogens for brain performance – Hemnia Creatine Monohydrate Creavitalis® and Cannaline Ashwagandha Resilient Adaptogen for focus, stress, and sleep; CanaturaWholesale logo at the bottom right

Natural vs. synthetic nootropics

“Natural” refers to substances that occur naturally in food (e.g., caffeine, omega-3, creatine) or are derived from plant or other natural extracts (e.g., rhodiola, ashwagandha).

“Synthetic” nootropics are primarily substances developed as medications (e.g., modafinil, methylphenidate), or laboratory-produced forms of certain nutrients.

Origin alone does not determine whether a substance is effective or safe. The key factors are dosage, quality, potential interactions, and available data.

What are the best nootropics? 10 nootropics with the best-documented effects

Below you will find nootropics that are either well-studied in healthy adults or are commonly used as medications (even if they are not intended to enhance performance in healthy individuals).

For herbal products, it is important to check their standardization and approach their effects realistically.

Name Type Main Effect Typical Dosage (Adults) Level of Evidence Risks Legal status in the EU
Caffeine natural alertness, attention 75–200 mg single dose well-documented effect insomnia, anxiety, tolerance food / dietary supplement
L-theanine natural calming, focus (often with caffeine) 100–200 mg moderately supported effect drowsiness in sensitive individuals dietary supplement
Creatine nutrient energy for cells, supports performance during exercise 3–5 g/day moderately supported effect digestive issues dietary supplement
Omega-3 natural long-term brain support 250–500 mg/day mixed results affects blood clotting (especially at higher doses) dietary supplement
Ginkgo Biloba herbal extract blood circulation, memory approx. 240 mg/day more for cognitive disorders than for healthy individuals risk of bleeding (especially with medications) supplement / herbal medicine
Rhodiola rosea adaptogen stress, fatigue 144–400 mg/day moderately supported effect insomnia, irritability supplement / herbal medicine
Ashwagandha adaptogen stress, sleep 300–600 mg/day more for stress than for performance drowsiness / sedation, digestive issues dietary supplement
Bacopa monnieri natural memory (long-term) ~300 mg/day limited and mixed results digestive issues, drowsiness dietary supplement
Modafinil medication alertness 200–400 mg/day effective mainly in specific situations insomnia, psychological side effects prescription medication
Methylphenidate medication attention individual minimal effects in healthy individuals + risks addiction, cardiovascular risks psychotropic substance + prescription

How to understand the efficacy and safety of nootropics?

With nootropics, it is important to consider several key factors:

  • The effect tends to depend on the situation: it is usually mild to moderate and becomes more pronounced, for example, during sleep deprivation, high stress, or lower baseline performance.
  • Products vary in quality: for plant extracts (e.g., rhodiola, ginkgo), it depends on the specific type of extract, standardization, and dosage.
  • Marketing vs. reality: dietary supplements are not allowed to make therapeutic claims, and their efficacy is not evaluated as strictly as that of pharmaceuticals.

Are nootropics safe?

For dietary supplements, the most common risks are related to quality and composition. These may include contamination, inappropriate combinations of substances, interactions with medications (e.g., anticoagulants), or unrealistic expectations.

At the EU level, dietary supplements are considered food products; the manufacturer is responsible for their safety, and their composition and labeling must comply with established rules.

At the same time, supplements must not be marketed as means of preventing or treating diseases.

With prescription drugs, specific contraindications and risks of adverse effects must be taken into account.

For example, modafinil is associated with serious risks, including skin and psychiatric reactions, so its use is limited to clearly defined indications.

Current and future market trends

1. The market will continue to grow, but market size varies significantly depending on the source.

The growth of the category is confirmed by multiple market reports, but absolute figures differ depending on methodology, the definition of “nootropics,” and the segments included.

For example, Fortune Business Insights estimates the global market at $6.65 billion in 2026, while Precedence Research projected $21.33 billion for 2025 and forecasts further growth between 2026 and 2035, expecting a long-term compound annual growth rate (CAGR) of around 14%.

Therefore, growth is a credible trend, although the specific market size should be interpreted with caution.

Estimated size of the global nootropics market from 2025 to 2035 in billions of USD, with a growth trend based on CAGR according to data from Precedence Research; CanaturaWholesale logo at the bottom right

2. Demand for natural nootropics and adaptogens is growing strongly.

Multiple sources indicate a shift away from “smart drugs” toward natural ingredients, particularly adaptogens, vitamins, and plant extracts.

Precedence Research directly cites growing demand for nootropics from natural sources, and Grand View Research describes the preference for natural and plant-based ingredients in Europe as one of the main drivers of the market.

3. Nootropics are moving from supplements into other categories, primarily beverages.

Euromonitor notes that claims about the effects of nootropics are no longer limited to dietary supplements but are spreading across categories.

Grand View Research also notes the rapid growth of the nootropic beverage segment, attributing it to the convenience of ready-to-drink formats containing ingredients such as caffeine, L-theanine, and adaptogens.

This is one of the most practical trends for 2026: not just capsules, but also functional drinks.

4. Trust, transparency, and clear communication of effects will be more important than ever.

NIQ reports that 62% of consumers globally are more skeptical of health claims made by food companies, and 82% want more transparent and understandable labeling.

This is crucial for nootropics, as it is a category where the gap between marketing and real evidence is often very apparent.

Furthermore, SPINS identifies “conscious consumption”—the push for transparency, values, and mindful purchasing—as one of the key macro trends for 2026.

5. Cognitive health is increasingly linked to mental well-being, sleep, and “aging well.”

NIQ does not view nootropics in isolation, but as part of a broader wellness shift: there is growing interest in mental performance (alertness), energy, relaxation, sleep, and healthy aging.

This means that in 2026, products situated within the broader context of “focus + stress + sleep + longevity” will sell better than purely aggressive promises like “brain hack.”

6.Personalization and “stacking” remain a strong commercial trend.

Precedence Research notes the growth of personalized approaches and combinations of multiple ingredients, i.e., “stacking.”

This also fits into the broader wellness trend that McKinsey associates with younger, digitally savvy consumers who are experimenting and seeking solutions for specific goals.

This is particularly relevant for positioning and the product portfolio.

7. Online sales will grow, but retail won’t disappear.

Grand View Research expects rapid growth in online retail for nootropics, but other reports show that offline remains very significant for now.

Precedence Research reports that the offline channel held over a 73% share in 2025.

So for 2026, it doesn’t look like it will be “online only,” but rather a combination of online and offline sales: online education, trust, and conversion often through brick-and-mortar retail, pharmacies, or specialty stores.

8. In the EU, there will be greater scrutiny of health claims, particularly regarding plant extracts.

From a regulatory perspective, this is a very important trend. The European Commission states that health claims in the EU must comply with established rules and that the issue of health claims for plant-based substances has not yet been fully resolved.

Furthermore, the European Court of Justice’s ruling from April 2025 reaffirmed the sensitivity surrounding the use of health claims for plant-based substances.

Practical implications for 2026: brands may want to leverage the potential of adaptogens and plant extracts, but their messaging will need to be more cautious and compliant with the law.

9. For Europe, the combination of natural origin and an emphasis on quality will be key.

Grand View Research directly states that growth in Europe is driven by a preference for natural ingredients, an aging population, e-commerce, and performance pressure among professionals and students.

At the same time, it notes that in Germany, for example, quality, certification, and testing play a major role. For the European market, therefore, a “trendy ingredient” is not enough—the importance of standardization, testing, and the trustworthy origin of raw materials is growing.

Nootropics in practice and market trends

Nootropics represent a broad and diverse category—ranging from common substances like caffeine or omega-3 to prescription medications.

As research and practice show, the effect is often context-dependent: it depends on sleep, stress, baseline condition, and the specific composition of the product.

For everyday use, therefore, it makes sense to view nootropics realistically. They are not “miraculous performance enhancers,” but rather tools that can support alertness, concentration, or stress management in certain situations.

From a market perspective, several clear trends are emerging. There is growing interest in natural ingredients, adaptogens, and functional products (e.g., beverages) that combine multiple benefits (e.g., focus, stress, and sleep).

At the same time, however, pressure is mounting for quality, transparency, and the proper use of health claims, particularly within the framework of EU regulations.

In practice, this means that, in the long term, the products that will succeed are primarily those with meaningful formulations, presented realistically, and compliant with legislation.

Nootropics are not just about performance, but are based on a holistic approach to cognitive health—that is, a balance between energy, stress, recovery, and long-term sustainability.

FAQ

1. Are nootropics legal?

Yes, but it depends on the specific type of product.

  • Dietary supplements are considered food products in the EU (Directive 2002/46/EC).
  • If a product claims therapeutic or preventive effects, it may fall under the category of medicinal products (Directive 2001/83/EC).
  • Health claims (e.g., “supports memory”) must comply with the approved list under Regulation (EC) No. 1924/2006.

For plant-based substances, it depends on the form, dosage, and labeling. They may be sold as a dietary supplement or as a herbal medicinal product (EMA monographs).

2. What are adaptogens and nootropics?

Adaptogens and nootropics are not the same thing, but in practice they often overlap.

Nootropics are substances designed to support cognitive functions, such as attention, memory, or mental performance.

Adaptogens are substances that help the body better cope with stress and support its overall balance. This “adaptogenic” effect is also described in EMA technical materials as support for stress resistance.

Where they overlap:

  • Stress and sleep have a significant impact on brain performance. If an adaptogen helps reduce stress or improve sleep, it can indirectly support concentration and performance as well.
  • Some adaptogens (e.g., rhodiola or ashwagandha) are therefore commonly used in products focused on “brain performance.”

Important for practical use

  • Adaptogens do not act as “fast-acting stimulants”; their effect is more gradual.
  • They are mostly used to manage stress and fatigue, not for an immediate boost in performance.
  • From a regulatory and evidence-based perspective, some adaptogens are evaluated based on traditional use, not always on modern clinical studies.

Nootropics target brain performance directly, whereas adaptogens influence it more indirectly (through stress and the body’s overall condition).

3. What are the strongest nootropics?

In terms of effect, the most commonly cited are:

  • Caffeine: has the best-documented immediate effect on alertness and attention. There are also approved health claims for these effects in the EU.
  • Caffeine + L-theanine: a combination that can support concentration with less of a “jittery” feeling; studies show a measurable effect on attention.
  • Creatine: known from the field of sports, but research also shows potential benefits for the brain, especially during stress or fatigue.
  • Omega-3 (EPA/DHA): benefits for overall health are well-documented, but the effect on cognition tends to be minor or context-dependent.

Strong effect (medication):

  • Modafinil: a medication used, for example, to treat narcolepsy; it increases alertness but is strictly for medical use.
  • Methylphenidate: used, for example, for ADHD; in healthy individuals, it has limited benefits and higher risks (including addiction).

In practice, substances classified as drugs generally have the strongest effects, which is precisely why they are regulated and not intended for general use.

The “strongest” nootropics do not necessarily mean the best or safest. In practice, it depends on the goal (alertness, stress, memory) and also on whether it is a dietary supplement or a medication.

With dietary supplements, the effect is usually milder, but the safety profile is also more favorable when used correctly.

4. What are the experiences with nootropics?

Experiences with nootropics vary in practice, and this is well supported by studies and reviews.

  • Short-term effects (stimulants): With substances like caffeine, users commonly report improved alertness and faster reaction times. This aligns with research showing improved attention and mental performance following acute use.
  • Combinations (e.g., caffeine + L-theanine): Experiences often describe a “clearer focus” without nervousness. Studies confirm that this combination can improve attention and certain cognitive parameters more than caffeine alone.
  • Long-term use (adaptogens, nutrients): For substances like theanine or other supplements, experiences are less consistent. Meta-analyses show that the effect varies depending on the specific function and may not always be demonstrable in all tests.
  • Medications (modafinil, methylphenidate): Users often describe a stronger effect (alertness, focus), but research shows that in healthy people, the benefits are generally small to moderate and situation-dependent (e.g., fatigue).
  • Reality vs. Expectations: Reviews indicate that healthy people often use nootropics to enhance performance, but the effects tend to be limited and highly individual.

User experiences are often positive, but they do not always correspond to the reality of studies. The outcome is influenced by sleep, stress, dosage, and expectations (placebo effect).

This information is current as of May 7, 2026 

 

Sources:

Studies and reviews (effectiveness of nootropics):

Specific substances:

Medicines (EMA, EU documents):

Herbal substances (EMA monographs):

Market data and trends:

EU Legislation:

 

Author:  Patricie Mikolášová 

 

   

Photo: AI, Canva

"All information provided on this website, as well as the information provided through this website, is for educational purposes only. None of the information contained herein is intended as a substitute for medical diagnosis and such information is not to be considered medical advice or recommended treatment. This website does not promote, endorse or advocate the legal or illegal use of narcotic drugs or psychotropic substances or the commission of any other illegal activity. Please see our Disclaimer for further information."

Recommended products5

%s ...
%s
%image %title %code %s
Trustpilot